In addition, amlexanox was able to stabilize GDAP1 mRNA harboring UGA-PTC and to restore the protein expression of GDAP1 in a CMT model of hiPSC-derived neuronal cells [149]. This evidence concerns the gene GDAP1 and Charcot-Marie-Tooth disease.